Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
Tobacco use is the leading preventable cause of death in the US and a major driver of health disparities. Among our tools for reducing the harms of tobacco is lung cancer screening (LCS). This study will combine a review of existing qualitative and quantitative data on barriers to lung cancer screening and smoking cessation in underserved populations, a quantitative analysis of predictors of lung cancer screening and smoking cessation treatment use among Massachusetts Federally Qualified Health Centers (FQHC)s, and a stakeholder advisory group to synthesize these data and select implementation strategies that reflects the critical determinants and the strengths and resource constraints of the Federally Qualified Health Centers (FQHC) context.
Full description
Aim 1) To design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke.
Aim 2) To assess the acceptability, appropriateness and feasibility of the implementation strategy among community health center staff.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
FQHC implementation team including staff in the intervention FQHCs and their lung screening partners
Exclusion criteria
FQHC staff or partners who leave the organization before end of study
Primary purpose
Allocation
Interventional model
Masking
9 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal